A method of treating a non-human dermatological disorder, wherein the method comprises topically administering to a non-human dermatological disorder a therapeutically effective amount of a topical composition containing: (1) an active component comprising at least one salicylate derivative; and (2) at least one pharmaceutically acceptable solubilizer.

Web www.patentalert.com

> Lipopolysaccharide .alpha.-2,3 sialyltransferase of campylobacter jejuni and its uses

~ 00359